Instituto Português de Oncologia
Porto 4200-072
0 studies enrolling now · 1 studies all time
What they study most
Metastatic Breast Cancer
Studies at this site
Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3)
— Completed